表紙
市場調査レポート

睡眠補助:技術および世界市場

Sleep Aids: Technologies and Global Markets

発行 BCC Research 商品コード 117620
出版日 ページ情報 英文 255 Pages
即納可能
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
睡眠補助:技術および世界市場 Sleep Aids: Technologies and Global Markets
出版日: 2014年06月27日 ページ情報: 英文 255 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

2013年、世界の睡眠補助市場は549億ドルの規模を記録しました。今後同市場は5.6%のCAGRで推移し、2014年には585億ドル、2019年には767億ドルの規模に達すると予測されています。

当レポートでは、睡眠を補助する各種製品と技術について調査し、睡眠障害の種類と概要、睡眠補助薬(処方薬・OTC薬・生薬類)、睡眠検査ラボ、睡眠時無呼吸症のための器具、マットレスおよび枕の市場規模の推移と予測、薬剤開発の動向、主要企業のプロファイル、主要製品などを詳細にわたってまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 正常睡眠・睡眠障害・治療法:概要

  • 正常睡眠
  • 正常睡眠の生理学

第4章 睡眠障害と治療法:概要

  • 不眠症
  • 睡眠時無呼吸
  • ナルコレプシー
  • むずむず脚症候群
  • 睡眠時随伴症
  • 交代勤務睡眠障害
  • いびき
  • 時差ぼけ

第5章 睡眠障害:疾病管理の概要

  • 在宅睡眠検査
  • ラボ内睡眠検査
  • 睡眠潜時反復検査
  • 持続的陽圧呼吸(CPAP:POSITIVE AIRWAY PRESSURE)滴定検査
  • 持続的陰圧呼吸治療
  • 経口器具による治療
  • 手術
  • メラトニンサプリメント
  • 不眠症の認知行動療法
  • 生薬
  • ホメオパシー
  • アロマセラピー

第6章 睡眠補助薬

  • ベンゾジアゼピン睡眠補助薬
  • 非ベンゾジアゼピン睡眠補助薬
  • メラトニン受容体作動薬(ロゼレム)
  • 睡眠補助としての抗鬱剤
  • 主要な睡眠治療薬の概要

第7章 睡眠補助デバイス:概要

  • 睡眠ポリグラフ
  • CPAP(POSITIVE AIRWAY PRESSURE)システム
  • 気道インターフェース
  • 家庭用睡眠検査機器
  • 治療のための経口器具
  • アクチグラフィ
  • 光線療法用デバイス
  • 音響機器

第8章 睡眠補助市場の規模・成長率

  • 処方薬
  • OTC薬
  • 生薬・自然の睡眠補助
  • 市場規模・成長予測
  • 世界の睡眠時無呼吸症市場
  • 睡眠研究所
  • マットレス・枕
  • 世界のマットレス・枕市場

第9章 睡眠産業における最近の発展

  • 承認薬
  • パイプライン薬
  • 米国の睡眠研究の資金状況

第10章 睡眠補助:市場サマリー

  • 総市場
  • 関連事業者:製品タイプ別

第11章 企業プロファイル

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: HLC081B

The global market for sleep aids totaled $54.9 billion in 2013. This market is estimated to grow at a compound annual growth rate (CAGR) of 5.6% to reach $58.5 billion in 2014 and $76.7 billion by 2019.

This report provides:

  • An overview of the global market for sleep aids and related technologies.
  • Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
  • Identification of the different disorders that manifest with sleep disorder symptoms.
  • Information on different methods used to enhance sleep including medications, devices, and laboratories.
  • Details on emerging technologies and developing trends.

image1

REPORT SCOPE

INTRODUCTION

STUDY GOALS AND OBJECTIVES

Insomnia, sleep apnea, restless leg syndrome (RLS), bruxism, narcolepsy and sleepwalking are all serious sleep disorders that bring about negative health consequences. Often undiagnosed and thus not treated, sleep disorders can not only take a toll on personal health but can also adverse effects on personal relationships and reduce worker productivity. In examining the steep increase in a variety of sleep disorders, this report will analyze the causes and available treatments for sleep disorder sufferers. This report describes in detail the overall market for sleep aids and then gives an account of the segment revenues.

REASONS FOR STUDY

This BCC Research study provides the latest highlights in the exciting area of sleep disorders. Research on the working of the human brain in relation to sleep is a fairly new area, with many new and novel theories. The discovery of new mechanisms and chemicals in the brain has provided expanding avenues for research and development (R&D) of products that are likely to alter the course of sleep disorders or modify the outcome. This study analyzes the current therapies for sleep disorders and new therapies that are in the pipeline. The report provides the latest information on leading products and R&D initiatives in the area of sleep disorders. Moreover, the report gives an extensive review of the market leading firms in this sector.

SCOPE OF STUDY

This analysis primarily focuses on the following sleep disorders:

  • Insomnia.
  • Sleep apnea.
  • RLS.
  • Bruxism.
  • Narcolepsy.
  • Sleepwalking.

The report discusses products, trends, new developments and compensation issues that are currently affecting or are likely to affect the market soon. Analyses are provided for each of the key companies in the major and minor market segments. The sleep aids and diagnostic centers discussed in this report include:

  • Medications.
    • Prescriptions.
    • Over-the-counter (OTC).
    • Herbal remedies.
  • Sleep laboratories.
  • Sleep apnea devices.
  • Mattresses and pillows.

All markets are further broken down into specific types of products that are discussed in detail, measuring current and potential market size, identifying current and potential market drivers, detailing from 2013, 2014 and 2019, and assessing the competitors in the market and their shares in respective markets.

METHODOLOGY AND INFORMATION SOURCES

Both primary and secondary research methodologies were used in preparing this research report. The information and analysis presented are based on extensive first-hand interviews with primary executives, product managers, clinical specialists and doctors involved in the sleep disorders arena. Background information was obtained from various government, business, medical journal and trade magazines sources. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as to formulate market projections.

ANALYST'S CREDENTIALS

P. Natana Raj is a medical analyst and has edited 24 market research reports in the past eight years, covering pharmaceuticals, medical devices, stem cells and beverages. He is a retired college professor with 32 years of experience in teaching biochemistry, biotechnology, biochemical pharmacology, molecular biology and genetics. Besides an M.Sc degree, he also holds diplomas in biochemistry, biochemical pharmacology, biotechnology and environmental biology.

Table of Contents

CHAPTER 1 INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR STUDY
  • SCOPE OF STUDY
  • METHODOLOGY AND INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 EXECUTIVE SUMMARY

  • SUMMARY TABLE A GLOBAL MARKET FOR SLEEP AIDS BY PRODUCT TYPE, THROUGH 2019 ($ BILLIONS)
  • SUMMARY FIGURE A GLOBAL MARKET FOR SLEEP AIDS BY PRODUCT TYPE, 2013-2019 ($ BILLIONS)
  • SUMMARY TABLE B GLOBAL MARKET SHARES FOR SLEEP AIDS: TECHNOLOGIES AND MARKETS BY REGION, 2013-2019 (%)
  • SUMMARY FIGURE B GLOBAL MARKET SHARES FOR SLEEP AIDS: TECHNOLOGIES AND MARKETS BY REGION, 2019 (%)

CHAPTER 3 NORMAL SLEEP, SLEEP DISORDERS AND TREATMENTS: AN OVERVIEW

  • NORMAL SLEEP
  • TABLE 1 NORMAL SLEEP ARCHITECTURE
  • PHYSIOLOGY OF NORMAL SLEEP
  • FIGURE 1 PROGRESSION OF SLEEP STATES ACROSS A SINGLE NIGHT IN YOUNG ADULT
    • NREM and REM Sleep Cycles
      • Four Stages of NREM Sleep
      • FIGURE 2 CHARACTERISTIC EEG ACTIVITY OF EACH OF THE FOUR STAGES OF NREM SLEEP
      • Stage 1 Sleep
      • Stage 2 Sleep
      • Stage 3 and 4 Sleep
    • REM Sleep
    • TABLE 2 PHYSIOLOGICAL CHANGES DURING NREM AND REM SLEEP
    • PHYSIOLOGY DURING SLEEP
    • FACTORS AFFECTING SLEEP
      • Light
      • Jet Lag and Shift Work
      • Pain, Anxiety and Other Medical Conditions
      • Medications and Other Substances
    • SLEEP DURATION BY AGE
    • FIGURE 3 SLEEP DURATION BY AGE (HOURS)

CHAPTER 4 SLEEP DISORDERS AND TREATMENTS: AN OVERVIEW

  • INSOMNIA
    • INSOMNIA: SYMPTOMS AND CAUSES
    • INSOMNIA: DIAGNOSIS AND SELF TESTS
    • INSOMNIA: TREATMENT
  • SLEEP APNEA
    • SLEEP APNEA: SYMPTOMS AND RISK FACTORS
    • SLEEP APNEA: DIAGNOSIS
    • SLEEP APNEA: TREATMENT
  • NARCOLEPSY
    • NARCOLEPSY: SYMPTOMS
    • NARCOLEPSY: TREATMENT
  • RESTLESS LEG SYNDROME
    • RESTLESS LEG SYNDROME: CAUSES AND SYMPTOMS
    • RESTLESS LEG SYNDROME TREATMENT
  • PARASOMNIAS
    • PARASOMNIAS: SYMPTOMS
    • PARASOMNIAS: DIAGNOSIS AND TREATMENT
  • SHIFT WORK DISORDER
    • SHIFT WORK DISORDER: TREATMENT
  • SNORING
    • SNORING: TREATMENTS
  • JET LAG
    • JET LAG: SYMPTOMS
    • JET LAG: TREATMENT

CHAPTER 5 SLEEP DISORDERS: AN OVERVIEW OF DISEASE MANAGEMENT

  • HOME SLEEP TESTING
    • PROCESS OF HOME SLEEP TESTING
  • IN-LAB SLEEP STUDY 3
    • IN-LAB SLEEP STUDY: TESTING PROCESS
  • MULTIPLE SLEEP LATENCY TEST
    • MSLT: TESTING PROCESS
  • CPAP TITRATION STUDY
    • PROCESS OF CPAP TITRATION STUDY
  • CONTINUOUS PASSIVE AIRWAY PRESSURE THERAPY
  • ORAL APPLIANCE THERAPY
  • SURGERY FOR SLEEP DISORDERS
  • MELATONIN SUPPLEMENTS
  • COGNITIVE BEHAVIORAL THERAPY FOR INSOMNIA
  • HERBAL MEDICINES FOR SLEEP DISORDERS
  • TABLE 3 HERBAL MEDICINES STUDIED FOR INSOMNIA
    • KAVA (PIPER METHYSTICUM)
    • VALERIANA OFFICINALIS
    • PASSIONFLOWER (PASSIFLORA)
    • HOPS (HUMULUS LUPULUS)
    • SOUR DATE (ZIZYPUS JUJUBE)
  • HOMEOPATHIC MEDICINES FOR SLEEP DISORDERS
    • COFFEA
    • GELSEMIUM
    • BELLADONA
    • NUX VOMICA
    • OPIUM
  • AROMATHERAPY FOR SLEEP

CHAPTER 6 SLEEP-AID MEDICATION: AN OVERVIEW

  • BENZODIAZEPINE SLEEP AIDS
  • NONBENZODIAZEPINE SLEEP AIDS
  • MELATONIN RECEPTOR AGONISTS (ROZEREM)
  • ANTIDEPRESSANTS AS SLEEP AIDS
  • BRIEF DESCRIPTION OF SOME POPULAR SLEEP MEDICATIONS
    • BUTISOL SODIUM (BUTABARBITAL SODIUM TABLETS)
      • Adverse Reactions with Butisol Sodium
    • DOXEPIN HYDROCHLORIDE
      • Adverse Reactions with Doxepin
    • ESTAZOLAM
      • Adverse Reactions with Estazolam
      • TABLE 4 ADVERSE EVENTS IN CLINICAL TRIALS WITH ESTAZOLAM
    • FLURAZEPAM 5
      • Adverse Reactions with Flurazepam
    • HALCION (TRIAZOLAM)
      • Adverse Reactions with Halcion
      • TABLE 5 ADVERSE EVENTS IN CLINICAL TRIALS WITH HALCION
    • HORIZANT (GABAPENTIN ENACARBIL)
      • Mechanism of Action
      • Adverse Reactions with Horizant
      • TABLE 6 ADVERSE EVENTS REPORTED IN CLINICAL TRIALS WITH HORIZANT
    • LUNESTA (ESZOPICLONE)
      • Mechanism of Action
      • Adverse Reactions With Lunesta
      • TABLE 7 ADVERSE EVENTS IN CLINICAL TRIALS WITH LUNESTA
    • MELATONIN PYRIDOXINE HCL
    • NUVIGIL (ARMODAFINIL)
    • Mechanism of Action
      • Adverse Reactions with Nuvigil
      • TABLE 8 ADVERSE EVENTS IN CLINICAL TRIALS WITH NUVIGIL
    • PROVIGIL (MODAFINIL)
      • Mechanism of Action
      • Adverse Reactions with Provigil
      • TABLE 9 ADVERSE EVENTS REPORTED IN CLINICAL TRIALS WITH PROVIGIL
    • QUAZEPAM
      • Clinical Study Experience with Quazepam
      • TABLE 10 ADVERSE EVENTS REPORTED IN CLINICAL TRIALS WITH QUAZEPAM
    • RESTORIL (TEMAZEPAM)
      • Adverse Reactions with Restoril
      • TABLE 11 ADVERSE EVENTS WITH RESTORIL IN CLINICAL TRIALS
    • ROZEREM (RAMELTEON)
      • Adverse Reactions with Rozerem
      • TABLE 12 ADVERSE EVENTS REPORTED IN CLINICAL TRIALS WITH ROZEREM
    • SECONAL SODIUM
      • Adverse Effects with Seconal Sodium
    • SOMNOTE (CHLORAL HYDRATE)
      • Adverse Reactions with Somnote
    • SONATA (ZALEPLON)
      • Mechanism of Action
      • Adverse Reactions with Sonata
      • TABLE 13 ADVERSE EVENTS OBSERVED IN CLINICAL TRIALS WITH SONATA
    • XYREM (SODIUM OXYBATE)
      • Mechanism of Action
      • Adverse Reactions with Xyrem
      • TABLE 14 ADVERSE REACTIONS WITH XYREM
    • ZOLPIDEM SL
      • Mechanism of Action
      • Adverse Reactions with Zolpidem SL
      • TABLE 15 ADVERSE EVENTS WITH ZOLPIDEM SL (PERCENTAGE OF PATIENTS REPORTING)
      • TABLE 16 ADVERSE EVENTS IN LONG-TERM PLACEBO-CONTROLLED CLINICAL TRIALS (PERCENTAGE OF PATIENTS REPORTING)
    • ZOLPIMIST (ZOLPIDEM TARTARATE)
      • Mechanism of Action
      • Adverse Reactions With Zolpimist
      • TABLE 17 ADVERSE EVENTS WITH ZOLPIMIST FOR TEN NIGHTS (% OF PATIENT REPORTING)
      • TABLE 18 ADVERSE EVENTS WITH ZOLPIMIST FOR 35 NIGHTS

CHAPTER 7 SLEEP-AID DEVICES: AN OVERVIEW

  • POLYSOMNOGRAPHY
    • PSG SYSTEMS: PRODUCT COMPARISONS
      • Easy III PSG
      • SomnoStar
      • Sapphire PSG
      • Grael
      • RemLogic PSG System
      • Comet XL PSG System
      • Natus Sleepworks PSG with XLTEK Connex Amplifier
      • AirPSG
      • Alice 5
      • Brain Wave II PSG (BWII PSG)
      • SOMNOscreen Plus PSG
      • Harmonie-S Sleep System
      • Easy III Amplifier With Easy III Software
      • Easy Ambulatory with Easy III Software
      • SomnoStar Software With z4 Amplifier
      • Sapphire PSG Amplifier with Crystal PSG Software
      • Grael HD-PSG Amplifier with ProFusion PSG 3 Software
      • Somté PSG System With ProFusion PSG 3 Software
      • Sandman Software with S4500/MDrive Amplifier
      • PSG-1100 Sleep System
      • Alice 6 LDxN With Sleepware G3
      • Galaxy PSG Diagnostic Platform With Jupiter Amplifier
      • Sleepvirtual BWIII
      • SOMNOscreen plus PSG with DOMINO Software
  • POSITIVE AIRWAY PRESSURE SYSTEMS (CPAP)
    • CPAP SYSTEMS: PRODUCT COMPARISON
      • IntelliPAP AutoAdjust
      • IntelliPAP AutoBilevel
      • F & P ICON+ Auto
      • F & P ICON+ Premo
      • Z1 CPAP System
      • System One REMstar Auto
      • S9 VPAP Auto
      • Transcend Auto
      • Transcend EZEX
      • The World's Smallest CPAP
    • CPAP ACCESSORIES WITH FAVORABLE REVIEWS
      • SoClean 2 CPAP Sanitizer
      • Control III (CPAP Disinfectant)
      • Hurricane HE
      • Gecko Nasal Pad and Zippered CPAP Tubing Wrap
      • PAPillow
      • SnuggleHose
      • Quartz
      • CPAP Pillow
      • Comfort Products from Pad a Cheek
      • CPAP Hose Lift V5
      • CPAPHolders
      • CPAP Nightstand
      • EZTalk
  • AIRWAY INTERFACES 8
    • PRODUCT COMPARISON OF INTERFACES
      • Willow Nasal Pillow Systems
      • Miran and Sopora Masks
      • Nonny Pediatric Mask
      • TAP PAP Nasal Pillow Mask
      • Winx Sleep Therapy System Mouthpiece
      • SNAPP 2.0 Direct Nasal Mask
      • SleepWeaver ADVANCE Soft Cloth Nasal CPAP Mask
      • SleepWeaver Anew Soft Cloth Full Face PAP Mask
      • SleepWeaver Elan Soft Cloth Nasal CPAP Mask
      • F & P Pilairo Q
      • 6700 Series Disposable V2 Mask
      • QUEST HOMECARE Full Face Mask
      • V2 Full Face CPAP Mask
      • Aloha Nasal Pillow System
      • Hybrid Dual-Airway Mask
      • Nasal-Aire II
      • Amara Full Face Mask
      • Nuance and Nuance Pro Gel Pillows Mask
      • Mirage FX Nasal Mask
      • Quattro Air
      • Swift FX Nasal Mask
      • MiniMe 2 Pediatric Mask
  • HOME SLEEP TESTING DEVICES
    • COMPARISON OF HOME SLEEP TESTING DEVICES
      • X4/Sleep Profiler
      • MediByte Jr
      • Apnea Trak with Easy III Software
      • SleepView Monitor + Web Portal
      • Somte
      • WatchPAT
      • SleepImage
      • Embletta MPR PG
      • Nomad
      • OxyHolter with LX Sleep
      • AccuSom
      • NOX-T3
      • Alice PDx
      • ApneaLink Plus
      • ARES
      • SOMNOscreen plus
  • ORAL APPLIANCE THERAPY PRODUCTS
    • PRODUCT COMPARISON
      • Apnea Guard
      • myTAP
      • TAP
      • ApneaRx
      • Adjustable TheraSnore
      • OASYS Oral/Nasal Airway System with Removable CPAP Pro
      • aveoTSD Tongue Stabilizing Device
      • Silent Nite sl
      • Herbst Appliance
      • MPowRx Snoring and Sleep Apnea Device
      • The Moses
      • Myerson EMA
      • Narval CC
      • Adjustable Dorsal
      • Full Breath Solution
      • Lamberg Sleep Well
      • ZQuiet Pro-Plus
      • SomnoDent Flex
      • SomnoDent G2
      • The Standard SUAD Device
      • The SUE 2G
      • The SUAD B-H
      • SomnoGuard AP
      • SomnoGuard SP Soft
  • ACTIGRAPHY
    • PRODUCT COMPARISON
      • wActiSleep-BT Monitor
      • Micro Motionlogger Watch
      • MotionWatch 8
      • Actiwatch Spectrum
      • SOMNOwatch
  • LIGHT THERAPY DEVICES
    • PRODUCT COMPARISON
      • BlueMax 70w Dimmable Light Therapy Desk Lamp
      • The Litebook Elite
      • SunSation
  • SOUND MACHINES
    • SOUND MACHINE PRODUCT COMPARISON
      • Sharper Image Sound Soother White Noise Machine EC-B100
      • HoMedics SoundSpa SS-6510
      • Sound Oasis S-650
      • Adaptive Sound Technologies SOUND + SLEEP
      • Brookstone Tranquil Moments Sleep Sound Therapy System
      • Sound Oasis Sound Therapy System S-550-04
      • Marsona DS-600A
      • Conair SU12-3PK
      • Marpac SleepMate 980A

CHAPTER 8 SLEEP-AID MARKET SIZE AND GROWTH

  • PRESCRIPTION SLEEP MEDICATIONS
  • TABLE 19 THE BEST-SELLING PRESCRIPTION SLEEPING PILLS
  • TABLE 20 ADVERSE EVENTS WITH ZOLPIDEM
    • EFFECTIVENESS OF NEWER SLEEPING PILLS
    • TABLE 21 EFFECTIVENESS OF AND DIFFERENCES BETWEEN NEWER SLEEPING PILLS
    • SIDE EFFECTS OF NEWER SLEEPING PILLS
    • TABLE 22 COMMON SIDE EFFECTS OF NEWER SLEEPING PILLS (%)
    • COST OF INSOMNIA DRUGS
    • TABLE 23 COST OF INSOMNIA DRUGS ($)
  • OVER-THE-COUNTER SLEEP MEDICATIONS
  • HERBAL AND NATURAL SLEEP AIDS
  • SLEEP-MEDICATION MARKET SIZE AND FORECAST
  • TABLE 24 GLOBAL MARKET FOR SLEEP-AID MEDICATION, THROUGH 2019 ($ BILLIONS)
  • FIGURE 4 GLOBAL MARKET FOR SLEEP-AID MEDICATION, 2013-2019 ($ BILLIONS)
    • GLOBAL MARKET FOR PRESCRIPTION SLEEP MEDICATIONS
    • TABLE 25 GLOBAL MARKET FOR PRESCRIPTION SLEEP-AID MEDICATION BY CATEGORY, THROUGH 2019 ($ BILLIONS)
    • FIGURE 5 GLOBAL MARKET FOR PRESCRIPTION SLEEP-AID MEDICATION BY CATEGORY, 2013-2019 ($ BILLIONS)
    • TABLE 26 NONBENZODIAZEPINES USED IN SLEEP DISORDERS
    • TABLE 27 NARCOLEPSY PRODUCTS
    • TABLE 28 BENZADIAZEPINES FOR INSOMNIA
    • TABLE 29 DRUGS PRESCRIBED FOR RESTLESS LEG SYNDROME
    • TABLE 30 MELATONIN RECEPTOR AGONISTS FOR SLEEP DISORDERS
    • GLOBAL MARKET FOR OTC/HERBAL SUPPLEMENTS
    • TABLE 31 GLOBAL MARKET FOR OTC/HERBAL SUPPLEMENTS FOR SLEEP DISORDERS, THROUGH 2019 ($ MILLIONS)
    • FIGURE 6 GLOBAL MARKET FOR OTC/HERBAL SUPPLEMENTS FOR SLEEP DISORDERS, 2013-2019 ($ MILLIONS)
      • OTC Analgesics and Combination Drugs
      • TABLE 32 ANALGESIC AND COMBINATION DRUGS FOR SLEEP
      • OTC Antihistamines for Sleep Disorders
      • TABLE 33 ANTIHISTAMINES FOR SLEEP DISORDERS
      • OTC Natural Sleep Aids
      • TABLE 34 NATURAL SLEEP AIDS
    • GLOBAL MARKET FOR SLEEP-AID MEDICATION BY REGION
    • TABLE 35 GLOBAL MARKET FOR SLEEP-AID MEDICATIONS BY REGION, THROUGH 2019 ($ BILLIONS)
    • FIGURE 7 GLOBAL MARKET FOR SLEEP-AID MEDICATIONS BY REGION, 2013-2019 ($ BILLIONS)
      • Prescription Sleep-Drug Use in the U.S.
      • FIGURE 8 PRESCRIPTION SLEEP-AID USE IN THE U.S. (%)
        • Prescription Sleep-Drug Use in the U.S. by Gender and Ethnicity
        • FIGURE 9 PRESCRIPTION SLEEP-AID USE IN THE U.S. BY GENDER AND ETHNICITY (%)
        • Ratings of Sleep Aids in the U.S.
        • TABLE 36 RATINGS OF SLEEP AIDS IN THE U.S.
  • GLOBAL MARKET FOR SLEEP APNEA
  • FIGURE 10 GLOBAL MARKET FOR SLEEP APNEA DEVICES, 2013-2019 ($ BILLIONS)
    • GLOBAL MARKET FOR SLEEP APNEA BY REGION
    • TABLE 37 GLOBAL MARKET FOR SLEEP APNEA DEVICES BY REGION, THROUGH 2019 ($ BILLIONS)
    • FIGURE 11 GLOBAL MARKET FOR SLEEP APNEA DEVICES BY REGION, 2013-2019 ($ BILLIONS)
      • Global Market for Auto-PAP Devices
      • FIGURE 12 GLOBAL MARKET FOR APAP DEVICES, 2013-2019 ($ MILLIONS)
        • U.S. Market for Sleep Apnea Devices by Product Type
        • FIGURE 13 U.S. MARKET FOR APNEA DEVICES BY PRODUCT TYPE IN UNIT SHIPMENT, 2013-2019 (NUMBER OF UNITS)
        • U.S. Market for CPAP Devices
        • FIGURE 14 U.S. MARKET FOR CPAP DEVICES IN UNIT SHIPMENT, 2013-2019 (NUMBER OF UNITS)
        • U.S. Market for Bi-Level Devices
        • FIGURE 15 U.S. MARKET FOR BI-LEVEL DEVICES IN UNIT SHIPMENT, 2013-2019 (NO. OF UNITS)
        • U.S. Market for APAP Devices 144
        • FIGURE 16 U.S. MARKET FOR APAP DEVICES IN UNIT SHIPMENT, 2013-2019 (NUMBER OF UNITS)
    • MEDICARE SPENDING FOR POLYSOMNOGRAPHY TESTS
    • TABLE 38 POLYSOMNOGRAPHY PROCEDURE PRICING IN THE U.S. ($)
    • FIGURE 17 MEDICARE SPENDING FOR POLYSOMNOGRAPHY TESTS, 2005-2013 ($ MILLIONS)
    • GLOBAL MARKET FOR AMBULATORY/HOME SLEEP-DIAGNOSTIC DEVICES
    • FIGURE 18 GLOBAL MARKET FOR AMBULATORY/HOME SLEEP-DIAGNOSTIC DEVICES, 2013-2019 ($ MILLIONS)
      • Advantages of Home Sleep Testing
      • Economics of Home Sleep Testing
      • Market Leaders in Home Sleep Testing Devices
      • FIGURE 19 HOME SLEEP TESTING DEVICES' MARKET SHARE BY COMPANY, 2013 (% SHARE)
  • SLEEP LABORATORIES
    • FIGURE 20 GLOBAL REVENUE FOR SLEEP LABORATORIES, 2013-2019 ($ BILLIONS)
    • TABLE 39 GLOBAL REVENUES FOR SLEEP LABORATORIES BY REGION, THROUGH 2019 ($ BILLIONS)
    • FIGURE 21 GLOBAL REVENUES FOR SLEEP LABORATORIES BY REGION, 2013-2019 ($ BILLIONS)
    • NUMBER OF SLEEP CENTERS IN THE U.S.
    • FIGURE 22 GROWTH IN NUMBER OF SLEEP CENTERS IN THE U.S., 1990-2013
    • HOME SLEEP TESTING IN THE U.S.
    • CURRENT OPTIONS IN PORTABLE SLEEP MARKET
  • MATTRESS AND PILLOW
    • TYPES OF MATTRESSES
      • Innerspring Mattresses
      • Memory Foam Mattresses
      • Inflatable Air Mattresses
      • Gel Mattresses
    • PILLOWS
      • Natural Fill Pillow
      • Synthetic Fill Pillow
      • Poly Cluster Fill Pillows
      • Foam Pillows
      • Memory Foam Pillows
  • GLOBAL MARKET FOR MATTRESSES AND PILLOWS
  • FIGURE 23 GLOBAL MARKET FOR MATTRESSES AND PILLOWS, 2013-2019 ($ BILLIONS)
  • TABLE 40 GLOBAL MARKET FOR MATTRESSES AND PILLOWS BY REGION, THROUGH 2019 ($ BILLIONS)
  • FIGURE 24 GLOBAL MARKET FOR MATTRESSES AND PILLOWS, 2013-2019 ($ BILLIONS)
  • FIGURE 25 GLOBAL MARKET FOR MATTRESSES AND PILLOWS BY REGION, 2019 (%)
    • MATTRESSES: THE LEADING HOUSEHOLD CONSUMABLES
    • FIGURE 26 MATTRESSES IN RELATION TO SOME HOUSEHOLD CONSUMABLES IN DEVELOPED MARKETS (%)
    • GLOBAL MATTRESS PRODUCTION BY MATERIAL
    • FIGURE 27 BREAKDOWN OF GLOBAL MATTRESS PRODUCTION BY MATERIAL, 2014 (%)
    • PRICE POINT COMPARISONS FOR MATTRESSES
    • TABLE 41 PRICE POINT COMPARISON OF MATTRESSES BY MARKET LEADERS, 2013
    • LEADING MATTRESS AND PILLOW VENDORS IN THE U.S.
    • FIGURE 28 U.S. BEDDING MARKET SHARE BY LEADING VENDORS (%)

CHAPTER 9 LATEST DEVELOPMENTS IN SLEEP INDUSTRY

  • SLEEP MEDICATION APPROVED IN 2014
    • HELTIOZ (TASIMELTEON)
      • Clinical Results
      • Side Effects
      • Mechanism of Action
  • SLEEP DISORDER MEDICATIONS IN THE PIPELINE
  • TABLE 42 SELECTED SLEEP DISORDER MOLECULES IN THE PIPELINE
  • SLEEP RESEARCH FUNDING IN THE U.S.
  • TABLE 43 NIH FUNDING FOR SLEEP RESEARCH, 2010-2015 ($ MILLIONS)

CHAPTER 10 SLEEP AIDS: MARKET SUMMARY

  • TOTAL MARKET
  • FIGURE 29 GLOBAL MARKET FOR SLEEP AIDS: TECHNOLOGIES AND MARKETS, 2013-2019 ($ BILLIONS)
    • TOTAL MARKET BY PRODUCT TYPE
    • TABLE 44 GLOBAL MARKET FOR SLEEP AIDS BY PRODUCT TYPE, THROUGH 2019 ($ BILLIONS)
    • FIGURE 30 GLOBAL MARKET FOR SLEEP AIDS BY PRODUCT TYPE, 2013-2019 ($ BILLIONS)
    • FIGURE 31 GLOBAL MARKET FOR SLEEP AIDS BY PRODUCT TYPE, 2019 (%)
    • TOTAL SLEEP-AID MARKET BY REGION
    • TABLE 45 GLOBAL MARKET SHARES FOR SLEEP AIDS: TECHNOLOGIES AND MARKETS BY REGION, 2013-2019 (%)
    • FIGURE 32 GLOBAL MARKET SHARES FOR SLEEP AIDS BY REGION, 2013-2019 (%)
  • INDUSTRY PARTICIPANTS BY PRODUCT TYPE
  • TABLE 46 SELECTED PARTICIPANTS BY PRODUCT TYPE, 2013

CHAPTER 11 COMPANY PROFILES

  • 3B MEDICAL INC.
    • BRIEF HISTORY
    • PRODUCTS
      • Willow Nasal Pillow Systems
      • iVolve Nasal Mask
      • RESmart BPAP Bi-level Positive Airway Pressure
      • RESmart Auto APAP
      • RESmart CPAP
      • Sleep View Sleep Screener
      • Polymate YH-1000 Polygraph
  • ACTIGRAPH LLC
    • BRIEF HISTORY
    • PRODUCTS
      • wGT3X-BT Monitor
      • wActiSleep-BT Monitor
      • ActiLife 6
  • ADVANCED BRAIN MONITORING INC.
    • BRIEF HISTORY
    • PRODUCTS
      • Sleep Profiler
      • Apnea Guard
      • Night Shift
  • AIRWAY MANAGEMENT INC.
    • BRIEF HISTORY
    • PRODUCTS
      • TAP 3 Elite
      • TAP 3
  • AMBULATORY MONITORING INC.
    • BRIEF HISTORY
    • PRODUCTS
      • Motionlogger Actigraph
      • Inductotrace
      • PVT-192 Psychomotor Vigilance Task Master
  • APNEA SCIENCES CORP.
    • BRIEF HISTORY
    • PRODUCT
      • ApneaRx
  • APNICURE INC.
    • BRIEF HISTORY
    • PRODUCT
      • Winx
  • BLAIREX LABORATORIES INC.
    • BRIEF HISTORY
    • PRODUCT
      • Sleepinal
  • BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
    • BRIEF HISTORY
    • PRODUCTS
      • Mirapexin
      • Sifrol
      • Pexola
      • Mirapex
  • BRAEBON MEDICAL
    • BRIEF HISTORY
    • SELECTED SLEEP PRODUCTS
      • PureFlow Oronasal Cannula & Filter Model 0597
      • PureFlow Duo Oronasal Cannula & Filter Model 0588
      • Nasal & Oral Luer Lock Cannula & Safety Filter Model 0589
      • Large Bore Nasal & Oral Cannula & Filter Model 0587
      • Adjustable and Nasal Luer Lock Cannula & Filter Model 0599
      • ValueFlow Nasal Cannula With Male Luer Lock Model 5582
      • Large Bore Nasal Cannula & Safety Filter Model 0582
      • Model 0582M CO2
      • Model 0582 CO2
      • PureFlow
      • Disposable Airflow
      • MediByte
      • MediByte Junior
      • DentiTrac
  • CADWELL LABORATORIES INC.
    • BRIEF HISTORY
    • SLEEP PRODUCTS
      • Easy III PSG
      • EASY Ambulatory PSG With Q-Video Mobile
      • EASY ApneaTrak
  • CAMNTECH LTD.
    • BRIEF HISTORY
    • PRODUCTS
      • MotionWatch 8
      • PRO-Diary
  • CAREFUSION CORP.
    • BRIEF HISTORY
    • PRODUCTS
      • SomnoStar z4 Sleep System
      • QDC-Pro
      • NOX-T3 Portable Sleep Monitor
      • ApneaRx Sleep Therapy Device
      • Advantage Series Full-Face Mask
      • IQ Nasal Mask
      • MiniMe Nasal Mask
      • Mojo Full-Face Mask
      • SNAPP 2.0 Nasal Interface
      • REVENUE HISTORY
      • TABLE 47 CAREFUSION'S REVENUES, 2010-2013 ($ MILLIONS)
  • CIRCADIANCE LLC
    • BRIEF HISTORY
    • PRODUCTS
      • SleepWeaver Anew
      • SleepWeaver Elan
      • SleepWeaver Advance
  • CLEVELAND MEDICAL DEVICES INC.
    • BRIEF HISTORY
    • PRODUCTS
      • SleepView
      • SleepScout
      • Sapphire PSG
  • COMPUMEDICS LTD.
    • BRIEF HISTORY
    • PRODUCTS
      • Grael-HD
      • Profusion Sleep 4
      • PROFusionDV
      • Somte PSG
      • Siesta 802 PSG
      • REVENUE HISTORY
      • TABLE 48 COMPUMEDIC'S REVENUES, 2010-2013 ($ THOUSANDS)
  • DEVILBISS HEALTHCARE LLC
    • BRIEF HISTORY
    • PRODUCTS
      • IntelliPAP Standard
      • IntelliPAP Standard Plus with SmartFlex
      • IntelliPAP AutoAdjust
      • IntelliPAP Bilevel S
      • IntelliPAP AutoBilevel
      • Nasal Masks
      • Full-Face Masks
      • Nasal Pillow Interfaces
      • Nasal Cannula Interfaces
      • Dual-Airway Interfaces
      • Therapy Management
      • Comfort Technologies
  • DISTAR LLC
    • BRIEF HISTORY
    • PRODUCTS
      • Original TheraSnore
      • Adjustable TheraSnore
      • TheraSnore II
  • DR. TOUSSAINT GMBH
    • BRIEF HISTORY
    • PRODUCTS 206
      • SomnoGuard AP
      • SomnoGuard AP Pro
      • SomnoGuard SP
      • SomnoGuard 3
      • SomnoShirt and SomnoCushion
      • Nasaline Snooze
  • ECR PHARMACEUTICALS
    • BRIEF HISTORY
    • PRODUCT
      • Zolpimist (Zolpidem Tartarate)
  • FISHER & PAYKEL HEALTHCARE CORP. LIMITED
    • BRIEF HISTORY
    • PRODUCTS
      • F&P Simplus
      • FlexiFit 431/432
      • Forma
      • F&P Eson
      • Zest Q 210
      • FlexiFit 405/406/407
      • Pilairo
      • Pilairo Q
      • Opus 360
      • Oracle
      • ICON+ Auto
      • ICON+ Premo
      • ICON+ Novo
      • SleepStyle CPAP Series
      • REVENUE HISTORY 212
      • TABLE 49 FISHER & PAYKEL'S REVENUES FROM SLEEP APNEA PRODUCTS, 2009-2013 ($ THOUSANDS)
  • GLIDEWELL LABORATORIES
    • BRIEF HISTORY
    • PRODUCTS
      • Silent Nite sl
      • aveoTSD
      • TAP/TAP 3 TL
      • EMA
  • HANS RUDOLPH INC.
    • BRIEF HISTORY
    • PRODUCTS
      • 7600 Series V2 CPAP & BiPAP Mask
  • HUMAN DESIGN MEDICAL LLC
    • BRIEF HISTORY
    • PRODUCTS
      • The Z1
  • INNOMED TECHNOLOGIES INC.
    • BRIEF HISTORY
    • PRODUCTS
      • Aspen
      • Aloha Nasal Pillow System
      • Hybrid Universal Interface
      • Nasal-Aire II
      • Nasal-Aire II Petite
      • Bravo CPAP Interface
      • Bravo II Nasal Pillow System
      • Sylent
  • INSPIRE MEDICAL SYSYTEMS INC.
    • BRIEF HISTORY
    • PRODUCT
      • Inspire Upper-Airway Stimulation
  • ITAMAR MEDICAL LIMITED
    • BRIEF HISTORY
    • PRODUCT
      • WatchPAT
  • JOHNSON & JOHNSON
    • BRIEF HISTORY
    • PRODUCT
      • Tylenol PM
  • MODERN DENTAL LABORATORY USA LLC
    • BRIEF HISTORY
    • PRODUCTS
      • Moses Appliance
      • EMA
  • NATUS MEDICAL INCORPORATED
    • BRIEF HISTORY
    • PRODUCTS
      • Comet-PLUS XL
      • Comet-PLUS Portable PSG
      • Comet PSG-New Headbox
      • AURA PSG Ambulatory Systems
      • AURA PSG LITE
      • Sleep Trek 3
      • Embla N7000 PSG Amplifier
      • Embla S4500 PSG Amplifier
      • Embla MDrive
      • Embla Titanium
      • SD32+ 23
      • Embletta Gold
      • Embletta X100
      • REVENUE HISTORY
      • TABLE 50 NATUS' REVENUES, 2009-013 ($ THOUSANDS)
  • NIHON KOHDEN AMERICA INC.
    • BRIEF HISTORY
    • PRODUCT
      • PSG-1100A
  • NORTHEAST MONITORING INC.
    • BRIEF HISTORY
    • PRODUCT
      • LX Sleep Software
  • NOVASOM INC.
    • BRIEF HISTORY
    • PRODUCTS
      • NovaSom QSG
      • AccuSom
  • NOX MEDICAL
    • BRIEF HISTORY
    • PRODUCTS
      • Nox T3 Sleep Monitor
      • Nox A1 PSG System
  • PFIZER INC.
    • BRIEF HISTORY
    • PRODUCTS
      • Advil PM
      • Zaleplon
      • REVENUE HISTORY
      • TABLE 51 COMPANY REVENUES, 2011-2013 ($ MILLIONS)
  • RESMED INC.
    • BRIEF HISTORY
    • PRODUCTS
      • S9 Sleep Therapy System
      • AutoSet CS-A
      • VPAP ST
      • VPAP ST with iVAPS
      • VPAP ST-A with iVAPS
      • S9 AutoSet
      • S9 Escape Auto
      • S9 Elite
      • Stellar 150
      • Stellar 100
      • AutoSet CS 2
      • VPAP Tx
      • Elisee 150
      • Elisee 350
      • VS III 23
      • H5i
      • H4i
      • ApneaLink Plus
      • ApneaLink
      • OTHER PRODUCTS FROM RESMED
      • RESMED'S MARKETS
      • REVENUE HISTORY
      • TABLE 52 RESMED'S REVENUES, 2009-2013 ($ THOUSANDS)
  • RESPIRONICS INC.
    • BRIEF HISTORY
    • PRODUCTS
      • System One Sleep Therapy Systems
      • BiPAP autoSV Advanced-System One
      • SleepMapper
      • Wisp Nasal Mask System
      • TrueBlue Nasal Mask
      • ComfortGel Nasal Mask
      • EasyLife Nasal Mask
      • ComfortClassic Nasal Mask
      • Profile Lite Nasal Mask
      • Naunce and Naunce Pro Pillow Masks
      • GoLife Pillow Masks for Men and Women
      • OptiLife Pillow Mask
      • Amara Full-Face Mask
      • ComfortGel Full Face Mask
      • FitLife Full-Face Mask
      • Total Face Mask
      • Alice 6 LDE Diagnostic System
      • Alice 6 LDx Diagnostic System
      • Alice PDx Portable Sleep-Diagnostic System
      • Stardust II Sleep Recorder
      • OmniLab Advanced Titration System
      • RUSleeping RTS Screener
      • Actiwatch Spectrum Plus
      • Actiwatch Spectrum PRO
      • REVENUE HISTORY
      • TABLE 53 PHILIPS' HEALTHCARE REVENUES, 2010-2013 (EUR MILLIONS)
  • SANOFI
    • BRIEF HISTORY
    • PRODUCTS
      • Zolpidem
      • REVENUE HISTORY
      • TABLE 54 SANOFI'S REVENUES, 2008-2013 (EUR MILLIONS)
  • SELECT COMFORT CORP.
    • BRIEF HISTORY
    • PRODUCTS
      • Classic Series
      • New Sleep Number c2 Bed
      • Sleep Number c3 Bed
      • Sleep Number c4 Bed
      • Performance Series Mattresses
      • Sleep Number p5 Bed
      • Sleep Number p6 Bed
      • Memory Foam Series Mattresses
      • Sleep Number m9 Bed
      • Sleep Number m7 Bed
      • Innovation Series Mattresses
      • Sleep Number i8 Bed
      • Sleep Number i10 Bed
      • Sleep Number x12 Bed
      • Specialty Beds
      • Sleep Number RV Mattress Deluxe
      • Sleep Number RV Mattress Premier
      • REVENUE HISTORY
      • TABLE 55 SELECT COMFORT CORP.'S REVENUES, 2008-2013 ($ MILLIONS)
  • SERTA INC.
    • BRIEF HISTORY
    • PRODUCTS
      • Innerspring Mattresses
      • Perfect Sleeper Essentials
      • Perfect Sleeper Smart Surface
      • Memory Foam Mattresses
      • iComfort
      • iComfort Directions
      • iComfort EFX
      • iComfort Perfect Elements
      • Memory Foam Hybrid Mattresses
      • Perfect Day iSeries
      • Trump Home iSeries
      • Bellagio at Home iSeries
  • SIMMONS BEDDING COMPANY
    • BRIEF HISTORY
    • PRODUCTS
      • Simmons CURV
      • Simmons BeautySleep
  • SLEEPMED INC.
    • BRIEF HISTORY
  • SOMNETICS INTERNATIONAL INC.
    • BRIEF HISTORY
    • PRODUCTS
      • Transcend Auto
      • Transcend EZEX
  • SLEEPVIRTUAL
    • BRIEF HISTORY
    • PRODUCTS
      • BWII Portable PSG
      • BW3 PSG/PSG and EEG in One Amplifier
  • SOMAXON PHARMACEUTICALS
    • BRIEF HISTORY
    • PRODUCT
      • Silenor (Doxepin Tablets)
  • SOMNOMED LIMITED
    • BRIEF HISTORY
    • PRODUCTS
      • SomnoDent
      • SomnoBrux
  • SOMNOMEDICS LLC
    • BRIEF HISTORY
    • PRODUCTS
      • SOMNOtouch RESP
      • SOMNOwatch plus RESP
      • SOMNOscreen Plus
  • STRONG DENTAL
    • BRIEF HISTORY
    • PRODUCTS
      • SUAD Device
      • The Morning Repositioner
      • TSA
  • SUNOVION PHARMACEUTICALS INC.
    • BRIEF HISTORY
    • PRODUCT
      • Lunesta
      • TABLE 56 U.S. SALES OF LUNESTA, 2011-2013 ($ THOUSANDS, UNITS IN THOUSANDS)
  • SYNTHON BV
    • BRIEF HISTORY
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED
    • BRIEF HISTORY
    • PRODUCT
      • Rozerem
      • REVENUE HISTORY
      • TABLE 57 TAKEDA'S REVENUES, 2009-2013 (JPY MILLIONS)
  • TEMPUR SEALY INTERNATIONAL INC.
    • BRIEF HISTORY
    • PRODUCTS
      • Tempur-Pedic
      • Tempur
      • Sealy Posturepedic
      • Sealy Optimum
      • REVENUE HISTORY
      • TABLE 58 TEMPUR SEALY'S REVENUES, 2009-2013 ($ MILLIONS)
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED
    • BRIEF HISTORY
    • PRODUCTS
      • Provigil (Modafinil)
      • Nuvigil (Armodafinil)
      • TABLE 59 U.S. RETAIL SALES OF PROVIGIL, 2011 THROUGH FIRST QUARTER OF 2012 ($ THOUSANDS, THOUSANDS OF UNITS)
  • VANDA PHARMACEUTICALS INC.
    • BRIEF HISTORY
    • PRODUCT
      • Heltioz (Tasimelteon)
  • XENOPORT INC.
    • BRIEF HISTORY
    • PRODUCT
      • Horizant (Gabapentin Encarbil)

LIST OF TABLES

  • SUMMARY TABLE A GLOBAL MARKET FOR SLEEP AIDS BY PRODUCT TYPE, THROUGH 2019 ($ BILLIONS)
  • SUMMARY TABLE B GLOBAL MARKET SHARES FOR SLEEP AIDS: TECHNOLOGIES AND MARKETS BY REGION, 2013-2019 (%)
  • TABLE 1 NORMAL SLEEP ARCHITECTURE
  • TABLE 2 PHYSIOLOGICAL CHANGES DURING NREM AND REM SLEEP
  • TABLE 3 HERBAL MEDICINES STUDIED FOR INSOMNIA
  • TABLE 4 ADVERSE EVENTS IN CLINICAL TRIALS WITH ESTAZOLAM
  • TABLE 5 ADVERSE EVENTS IN CLINICAL TRIALS WITH HALCION
  • TABLE 6 ADVERSE EVENTS REPORTED IN CLINICAL TRIALS WITH HORIZANT
  • TABLE 7 ADVERSE EVENTS IN CLINICAL TRIALS WITH LUNESTA
  • TABLE 8 ADVERSE EVENTS IN CLINICAL TRIALS WITH NUVIGIL
  • TABLE 9 ADVERSE EVENTS REPORTED IN CLINICAL TRIALS WITH PROVIGIL
  • TABLE 10 ADVERSE EVENTS REPORTED IN CLINICAL TRIALS WITH QUAZEPAM
  • TABLE 11 ADVERSE EVENTS WITH RESTORIL IN CLINICAL TRIALS
  • TABLE 12 ADVERSE EVENTS REPORTED IN CLINICAL TRIALS WITH ROZEREM
  • TABLE 13 ADVERSE EVENTS OBSERVED IN CLINICAL TRIALS WITH SONATA
  • TABLE 14 ADVERSE REACTIONS WITH XYREM
  • TABLE 15 ADVERSE EVENTS WITH ZOLPIDEM SL (PERCENTAGE OF PATIENTS REPORTING)
  • TABLE 16 ADVERSE EVENTS IN LONG-TERM PLACEBO-CONTROLLED CLINICAL TRIALS (PERCENTAGE OF PATIENTS REPORTING)
  • TABLE 17 ADVERSE EVENTS WITH ZOLPIMIST FOR TEN NIGHTS (% OF PATIENT REPORTING)
  • TABLE 18 ADVERSE EVENTS WITH ZOLPIMIST FOR 35 NIGHTS
  • TABLE 19 THE BEST-SELLING PRESCRIPTION SLEEPING PILLS
  • TABLE 20 ADVERSE EVENTS WITH ZOLPIDEM
  • TABLE 21 EFFECTIVENESS OF AND DIFFERENCES BETWEEN NEWER SLEEPING PILLS
  • TABLE 22 COMMON SIDE EFFECTS OF NEWER SLEEPING PILLS (%)
  • TABLE 23 COST OF INSOMNIA DRUGS ($)
  • TABLE 24 GLOBAL MARKET FOR SLEEP-AID MEDICATION, THROUGH 2019 ($ BILLIONS) 121
  • TABLE 25 GLOBAL MARKET FOR PRESCRIPTION SLEEP-AID MEDICATION BY CATEGORY, THROUGH 2019 ($ BILLIONS)
  • TABLE 26 NONBENZODIAZEPINES USED IN SLEEP DISORDERS
  • TABLE 27 NARCOLEPSY PRODUCTS
  • TABLE 28 BENZADIAZEPINES FOR INSOMNIA
  • TABLE 29 DRUGS PRESCRIBED FOR RESTLESS LEG SYNDROME
  • TABLE 30 MELATONIN RECEPTOR AGONISTS FOR SLEEP DISORDERS
  • TABLE 31 GLOBAL MARKET FOR OTC/HERBAL SUPPLEMENTS FOR SLEEP DISORDERS, THROUGH 2019 ($ MILLIONS)
  • TABLE 32 ANALGESIC AND COMBINATION DRUGS FOR SLEEP
  • TABLE 33 ANTIHISTAMINES FOR SLEEP DISORDERS
  • TABLE 34 NATURAL SLEEP AIDS
  • TABLE 35 GLOBAL MARKET FOR SLEEP-AID MEDICATIONS BY REGION, THROUGH 2019 ($ BILLIONS)
  • TABLE 36 RATINGS OF SLEEP AIDS IN THE U.S.
  • TABLE 37 GLOBAL MARKET FOR SLEEP APNEA DEVICES BY REGION, THROUGH 2019 ($ BILLIONS)
  • TABLE 38 POLYSOMNOGRAPHY PROCEDURE PRICING IN THE U.S. ($)
  • TABLE 39 GLOBAL REVENUES FOR SLEEP LABORATORIES BY REGION, THROUGH 2019 ($ BILLIONS)
  • TABLE 40 GLOBAL MARKET FOR MATTRESSES AND PILLOWS BY REGION, THROUGH 2019 ($ BILLIONS)
  • TABLE 41 PRICE POINT COMPARISON OF MATTRESSES BY MARKET LEADERS, 2013
  • TABLE 42 SELECTED SLEEP DISORDER MOLECULES IN THE PIPELINE
  • TABLE 43 NIH FUNDING FOR SLEEP RESEARCH, 2010-2015 ($ MILLIONS)
  • TABLE 44 GLOBAL MARKET FOR SLEEP AIDS BY PRODUCT TYPE, THROUGH 2019 ($ BILLIONS)
  • TABLE 45 GLOBAL MARKET SHARES FOR SLEEP AIDS: TECHNOLOGIES AND MARKETS BY REGION, 2013-2019 (%)
  • TABLE 46 SELECTED PARTICIPANTS BY PRODUCT TYPE, 2013
  • TABLE 47 CAREFUSION'S REVENUES, 2010-2013 ($ MILLIONS)
  • TABLE 48 COMPUMEDIC'S REVENUES, 2010-2013 ($ THOUSANDS)
  • TABLE 49 FISHER & PAYKEL'S REVENUES FROM SLEEP APNEA PRODUCTS, 2009-2013 ($ THOUSANDS)
  • TABLE 50 NATUS' REVENUES, 2009-013 ($ THOUSANDS)
  • TABLE 51 COMPANY REVENUES, 2011-2013 ($ MILLIONS)
  • TABLE 52 RESMED'S REVENUES, 2009-2013 ($ THOUSANDS)
  • TABLE 53 PHILIPS' HEALTHCARE REVENUES, 2010-2013 (EUR MILLIONS)
  • TABLE 54 SANOFI'S REVENUES, 2008-2013 (EUR MILLIONS)
  • TABLE 55 SELECT COMFORT CORP.'S REVENUES, 2008-2013 ($ MILLIONS)
  • TABLE 56 U.S. SALES OF LUNESTA, 2011-2013 ($ THOUSANDS, UNITS IN THOUSANDS)
  • TABLE 57 TAKEDA'S REVENUES, 2009-2013 (JPY MILLIONS)
  • TABLE 58 TEMPUR SEALY'S REVENUES, 2009-2013 ($ MILLIONS)
  • TABLE 59 U.S. RETAIL SALES OF PROVIGIL, 2011 THROUGH FIRST QUARTER OF 2012 ($ THOUSANDS, THOUSANDS OF UNITS)

LIST OF FIGURES

  • SUMMARY FIGURE A GLOBAL MARKET FOR SLEEP AIDS BY PRODUCT TYPE, 2013-2019 ($ BILLIONS)
  • SUMMARY FIGURE B GLOBAL MARKET SHARES FOR SLEEP AIDS: TECHNOLOGIES AND MARKETS BY REGION, 2019 (%)
  • FIGURE 1 PROGRESSION OF SLEEP STATES ACROSS A SINGLE NIGHT IN YOUNG ADULT
  • FIGURE 2 CHARACTERISTIC EEG ACTIVITY OF EACH OF THE FOUR STAGES OF NREM SLEEP
  • FIGURE 3 SLEEP DURATION BY AGE (HOURS)
  • FIGURE 4 GLOBAL MARKET FOR SLEEP-AID MEDICATION, 2013-2019 ($ BILLIONS)
  • FIGURE 5 GLOBAL MARKET FOR PRESCRIPTION SLEEP-AID MEDICATION BY CATEGORY, 2013-2019 ($ BILLIONS)
  • FIGURE 6 GLOBAL MARKET FOR OTC/HERBAL SUPPLEMENTS FOR SLEEP DISORDERS, 2013-2019 ($ MILLIONS)
  • FIGURE 7 GLOBAL MARKET FOR SLEEP-AID MEDICATIONS BY REGION, 2013-2019 ($ BILLIONS)
  • FIGURE 8 PRESCRIPTION SLEEP-AID USE IN THE U.S. (%)
  • FIGURE 9 PRESCRIPTION SLEEP-AID USE IN THE U.S. BY GENDER AND ETHNICITY (%)
  • FIGURE 10 GLOBAL MARKET FOR SLEEP APNEA DEVICES, 2013-2019 ($ BILLIONS)
  • FIGURE 11 GLOBAL MARKET FOR SLEEP APNEA DEVICES BY REGION, 2013-2019 ($ BILLIONS)
  • FIGURE 12 GLOBAL MARKET FOR APAP DEVICES, 2013-2019 ($ MILLIONS)
  • FIGURE 13 U.S. MARKET FOR APNEA DEVICES BY PRODUCT TYPE IN UNIT SHIPMENT, 2013-2019 (NUMBER OF UNITS)
  • FIGURE 14 U.S. MARKET FOR CPAP DEVICES IN UNIT SHIPMENT, 2013-2019 (NUMBER OF UNITS)
  • FIGURE 15 U.S. MARKET FOR BI-LEVEL DEVICES IN UNIT SHIPMENT, 2013-2019 (NO. OF UNITS)
  • FIGURE 16 U.S. MARKET FOR APAP DEVICES IN UNIT SHIPMENT, 2013-2019 (NUMBER OF UNITS)
  • FIGURE 17 MEDICARE SPENDING FOR POLYSOMNOGRAPHY TESTS, 2005-2013 ($ MILLIONS)
  • FIGURE 18 GLOBAL MARKET FOR AMBULATORY/HOME SLEEP-DIAGNOSTIC DEVICES, 2013-2019 ($ MILLIONS)
  • FIGURE 19 HOME SLEEP TESTING DEVICES' MARKET SHARE BY COMPANY, 2013 (% SHARE)
  • FIGURE 20 GLOBAL REVENUE FOR SLEEP LABORATORIES, 2013-2019 ($ BILLIONS)
  • FIGURE 21 GLOBAL REVENUES FOR SLEEP LABORATORIES BY REGION, 2013-2019 ($ BILLIONS)
  • FIGURE 22 GROWTH IN NUMBER OF SLEEP CENTERS IN THE U.S., 1990-2013
  • FIGURE 23 GLOBAL MARKET FOR MATTRESSES AND PILLOWS, 2013-2019 ($ BILLIONS)
  • FIGURE 24 GLOBAL MARKET FOR MATTRESSES AND PILLOWS, 2013-2019 ($ BILLIONS)
  • FIGURE 25 GLOBAL MARKET FOR MATTRESSES AND PILLOWS BY REGION, 2019 (%)
  • FIGURE 26 MATTRESSES IN RELATION TO SOME HOUSEHOLD CONSUMABLES IN DEVELOPED MARKETS (%)
  • FIGURE 27 BREAKDOWN OF GLOBAL MATTRESS PRODUCTION BY MATERIAL, 2014 (%)
  • FIGURE 28 U.S. BEDDING MARKET SHARE BY LEADING VENDORS (%)
  • FIGURE 29 GLOBAL MARKET FOR SLEEP AIDS: TECHNOLOGIES AND MARKETS, 2013-2019 ($ BILLIONS)
  • FIGURE 30 GLOBAL MARKET FOR SLEEP AIDS BY PRODUCT TYPE, 2013-2019 ($ BILLIONS)
  • FIGURE 31 GLOBAL MARKET FOR SLEEP AIDS BY PRODUCT TYPE, 2019 (%)
  • FIGURE 32 GLOBAL MARKET SHARES FOR SLEEP AIDS BY REGION, 2013-2019 (%)
Back to Top